Cargando…

Weight Loss for Obese Prostate Cancer Patients on Androgen Deprivation Therapy

PURPOSE: Excess fat mass (FM) contributes to poor prostate cancer (PCa) prognosis and comorbidity. However, FM gain is a common side effect of androgen deprivation therapy (ADT). We examined the efficacy of a 12-wk weight loss intervention to reduce FM and maintain lean mass (LM) in ADT-treated obes...

Descripción completa

Detalles Bibliográficos
Autores principales:	WILSON, REBEKAH L., NEWTON, ROBERT U., TAAFFE, DENNIS R., HART, NICOLAS H., LYONS-WALL, PHILIPPA, GALVÃO, DANIEL A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Clinical Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886363/ https://www.ncbi.nlm.nih.gov/pubmed/33009195 http://dx.doi.org/10.1249/MSS.0000000000002509

Ejemplares similares

Using Exercise and Nutrition to Alter Fat and Lean Mass in Men with Prostate Cancer Receiving Androgen Deprivation Therapy: A Narrative Review
por: Wilson, Rebekah L., et al.
Publicado: (2021)

Maintaining Weight Loss in Obese Men with Prostate Cancer Following a Supervised Exercise and Nutrition Program—A Pilot Study
por: Wilson, Rebekah L., et al.
Publicado: (2021)

Reduced Cardiovascular Capacity and Resting Metabolic Rate in Men with Prostate Cancer Undergoing Androgen Deprivation: A Comprehensive Cross-Sectional Investigation
por: Wall, Bradley A., et al.
Publicado: (2015)

Examining the effects of creatine supplementation in augmenting adaptations to resistance training in patients with prostate cancer undergoing androgen deprivation therapy: a randomised, double-blind, placebo-controlled trial
por: Fairman, Ciaran M, et al.
Publicado: (2019)

Nationwide Industry-Led Community Exercise Program for Men With Locally Advanced, Relapsed, or Metastatic Prostate Cancer on Androgen-Deprivation Therapy
por: Schumacher, Oliver, et al.
Publicado: (2022)

Myokine Expression and Tumor-Suppressive Effect of Serum after 12 wk of Exercise in Prostate Cancer Patients on ADT
por: KIM, JIN-SOO, et al.
Publicado: (2022)

Does exercise impact gut microbiota composition in men receiving androgen deprivation therapy for prostate cancer? A single-blinded, two-armed, randomised controlled trial
por: Newton, Robert U, et al.
Publicado: (2019)

Psychological distress in men with prostate cancer undertaking androgen deprivation therapy: modifying effects of exercise from a year-long randomized controlled trial
por: Galvão, Daniel A., et al.
Publicado: (2021)

Androgen deprivation and cognition in prostate cancer
por: Salminen, E, et al.
Publicado: (2003)

Resistance Exercise Dosage in Men with Prostate Cancer: Systematic Review, Meta-analysis, and Meta-regression
por: LOPEZ, PEDRO, et al.
Publicado: (2021)

Weight loss for overweight and obese patients with prostate cancer: a study protocol of a randomised trial comparing clinic-based versus Telehealth delivered EXercise and nutrition intervention (the TelEX trial)
por: Galvão, Daniel A, et al.
Publicado: (2022)

Obesity and the Odds of Weight Gain following Androgen Deprivation Therapy for Prostate Cancer
por: Braunstein, Lior Z., et al.
Publicado: (2014)

Immediate versus delayed exercise in men initiating androgen deprivation: effects on bone density and soft tissue composition
por: Taaffe, Dennis R., et al.
Publicado: (2018)

Exercise Preserves Physical Function in Prostate Cancer Patients with Bone Metastases
por: GALVÃO, DANIEL A., et al.
Publicado: (2018)

Integrating diet and exercise into care of prostate cancer patients on androgen deprivation therapy
por: Moyad, Mark A, et al.
Publicado: (2016)

Metabolomic effects of androgen deprivation therapy treatment for prostate cancer
por: Chi, Jen‐Tsan, et al.
Publicado: (2020)

Can exercise ameliorate treatment toxicity during the initial phase of testosterone deprivation in prostate cancer patients? Is this more effective than delayed rehabilitation?
por: Newton, Robert U, et al.
Publicado: (2012)

Prostate Cancer Survivorship: Prevention and Treatment of the Adverse Effects of Androgen Deprivation Therapy
por: Saylor, Philip J., et al.
Publicado: (2009)

Adjuvant androgen deprivation impacts late rectal toxicity after conformal radiotherapy of prostate carcinoma
por: Sanguineti, G, et al.
Publicado: (2002)

Androgen deprivation therapy in high risk prostate cancer
por: Van Dams, Ritchell, et al.
Publicado: (2019)

Androgen-Deprivation Therapy and Cardiovascular Disease Risk – The Role of Exercise in Prostate Cancer Treatment
por: Wall, Bradley
Publicado: (2016)

An Update on the Changing Indications for Androgen Deprivation Therapy for Prostate Cancer
por: Myklak, Kristene, et al.
Publicado: (2011)

Predictors of early androgen deprivation treatment failure in prostate cancer with bone metastases
por: Varenhorst, Eberhard, et al.
Publicado: (2016)

Androgen Deprivation Therapy Is Associated With Prolongation of QTc Interval in Men With Prostate Cancer
por: Gagliano-Jucá, Thiago, et al.
Publicado: (2018)

Exercise modulation of tumour perfusion and hypoxia to improve radiotherapy response in prostate cancer
por: Schumacher, Oliver, et al.
Publicado: (2020)

Exercise in advanced prostate cancer elevates myokine levels and suppresses in-vitro cell growth
por: Kim, Jin-Soo, et al.
Publicado: (2022)

Predictors of Fracture Risk and Bone Mineral Density in Men with Prostate Cancer on Androgen Deprivation Therapy
por: Neubecker, Katherine, et al.
Publicado: (2011)

What is the minimal dose for resistance exercise effectiveness in prostate cancer patients? Systematic review and meta-analysis on patient-reported outcomes
por: Lopez, Pedro, et al.
Publicado: (2020)

Prostate cancer, insulin, and androgen deprivation therapy
por: Stattin, P, et al.
Publicado: (2003)

The effect of continuous androgen deprivation treatment on prostate cancer patients as compared with intermittent androgen deprivation treatment
por: Ku, Ja Yoon, et al.
Publicado: (2015)

Loss of SNAI2 in Prostate Cancer Correlates With Clinical Response to Androgen Deprivation Therapy
por: Cmero, Marek, et al.
Publicado: (2021)

The clinical guiding value of a radiomics model for androgen deprivation therapy for prostate cancer
por: Yu, Na, et al.
Publicado: (2021)

Pre-treatment nomogram for biochemical control after neoadjuvant androgen deprivation and radical radiotherapy for clinically localised prostate cancer
por: Parker, C C, et al.
Publicado: (2002)

A phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer
por: Newton, Robert U, et al.
Publicado: (2009)

The Current Practice of Screening, Prevention, and Treatment of Androgen-Deprivation-Therapy Induced Osteoporosis in Patients with Prostate Cancer
por: Al-Shamsi, Humaid O., et al.
Publicado: (2012)

Resistance Exercise Training Increases Muscle Mass and Strength in Prostate Cancer Patients on Androgen Deprivation Therapy
por: HOUBEN, LISANNE H. P., et al.
Publicado: (2023)

Steroid Hormone Biosynthesis Metabolism Is Associated With Fatigue Related to Androgen Deprivation Therapy for Prostate Cancer
por: Feng, Li Rebekah, et al.
Publicado: (2021)

Can exercise delay transition to active therapy in men with low-grade prostate cancer? A multicentre randomised controlled trial
por: Galvão, Daniel A, et al.
Publicado: (2018)

Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells
por: Chen, Mengqian, et al.
Publicado: (2010)

Duration of androgen deprivation therapy with maximum androgen blockade for localized prostate cancer
por: Fujimoto, Naohiro, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_jjhrf7e43tr7kn2tk775nfelku